GenIbet Biopharmaceuticals Email Format
Biotechnology ResearchLisbon, Portugal51-200 Employees
GenIbet Biopharmaceuticals is a mid-sized contract development and manufacturing organization based in Oeiras, near Lisbon, Portugal. It provides specialized development and cGMP production for microbial, cell culture, and viral propagation processes, with in-house fill-and-finish capabilities that allow clients to progress from bench to clinic within a single facility. The company focuses on manufacturing materials for early-stage drug development, preclinical studies, and cGMP manufacturing from Phase I to Phase III. Its client base includes research groups and biotech or pharmaceutical companies seeking integrated process development, manufacturing, and quality assurance support. In January 2022, GenIbet was acquired by Recipharm, a Sweden-headquartered contract development and manufacturing organization.